CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AC4. A total of 21 filers reported holding CLOVIS ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,874,000 | -12.6% | 3,000,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,145,000 | -5.3% | 3,000,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,265,000 | +9.4% | 3,000,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $2,070,000 | -5.5% | 3,000,000 | 0.0% | 0.00% | – |
| Q3 2021 | $2,190,000 | -1.0% | 3,000,000 | 0.0% | 0.00% | – |
| Q2 2021 | $2,213,000 | +0.7% | 3,000,000 | 0.0% | 0.00% | – |
| Q1 2021 | $2,198,000 | -22.3% | 3,000,000 | -25.0% | 0.00% | -100.0% |
| Q4 2020 | $2,830,000 | +4.0% | 4,000,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,720,000 | +13.3% | 4,000,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $2,400,000 | -7.7% | 4,000,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $2,600,000 | +0.8% | 4,000,000 | +23.1% | 0.00% | 0.0% |
| Q3 2018 | $2,580,000 | -16.0% | 3,250,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $3,070,000 | – | 3,250,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|